Clinical Trial Update: A Study to Characterize the Phenotype in Patients With Morton's Neuroma and to Explore the Effect of Local Administration of Xylocaine (Lidocaine) [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 study to characterize the phenotype of patients with Morton's neuroma and to explore the effect of locally administered lidocaine (Xylocaine).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morton Neuroma

Drugs mentioned

• Xylocaine (Lidocaine) (lidocaine)

Snippet

Sponsor: AstraZeneca | Conditions: Morton's Neuroma | EARLY_Phase 1 | Status: COMPLETED